TAGI Pharma Announces Exclusive Marketing Rights Agreement for Alendronate Sodium Oral Solution, 70mg/75ml x 4 Pack Unit of Use
30 avr. 2013 11h22 HE
|
TAGI Pharma, Inc.
SOUTH BELOIT, Ill., April 30, 2013 (GLOBE NEWSWIRE) -- TAGI Pharma, Inc., a specialty pharmaceutical company and subsidiary of Precision Dose, Inc., announced today the signing of an exclusive...
TAGI Pharma Announces Exclusive Marketing Rights Agreement for Codeine Sulfate Oral Solution CII, 30MG/5ML
10 avr. 2012 08h30 HE
|
TAGI Pharma, Inc.
SOUTH BELOIT, Ill., April 10, 2012 (GLOBE NEWSWIRE) -- TAGI Pharma, Inc., a subsidiary of Precision Dose, Inc., announced today the signing of an exclusive marketing rights agreement to market and...